Farzaneh, F., Moridi, A., Azizmohammadi, Z., Ansari J, M., Hosseini, M., Arab, M., Ashrafganjoei, T., Mazaheri, M. (2017). Value of Sentinel Lymph Node (SLN) Mapping and Biopsy using Combined Intracervical Radiotracers and Blue Dye Injections for Endometrial Cancer. Asian Pacific Journal of Cancer Prevention, 18(2), 431-435. doi: 10.22034/APJCP.2017.18.2.431
Farah Farzaneh; Atefeh Moridi; Zahra Azizmohammadi; Mojtaba Ansari J; Maryam Sadat Hosseini; Maliheh Arab; Tahereh Ashrafganjoei; Mina Mazaheri. "Value of Sentinel Lymph Node (SLN) Mapping and Biopsy using Combined Intracervical Radiotracers and Blue Dye Injections for Endometrial Cancer". Asian Pacific Journal of Cancer Prevention, 18, 2, 2017, 431-435. doi: 10.22034/APJCP.2017.18.2.431
Farzaneh, F., Moridi, A., Azizmohammadi, Z., Ansari J, M., Hosseini, M., Arab, M., Ashrafganjoei, T., Mazaheri, M. (2017). 'Value of Sentinel Lymph Node (SLN) Mapping and Biopsy using Combined Intracervical Radiotracers and Blue Dye Injections for Endometrial Cancer', Asian Pacific Journal of Cancer Prevention, 18(2), pp. 431-435. doi: 10.22034/APJCP.2017.18.2.431
Farzaneh, F., Moridi, A., Azizmohammadi, Z., Ansari J, M., Hosseini, M., Arab, M., Ashrafganjoei, T., Mazaheri, M. Value of Sentinel Lymph Node (SLN) Mapping and Biopsy using Combined Intracervical Radiotracers and Blue Dye Injections for Endometrial Cancer. Asian Pacific Journal of Cancer Prevention, 2017; 18(2): 431-435. doi: 10.22034/APJCP.2017.18.2.431
Value of Sentinel Lymph Node (SLN) Mapping and Biopsy using Combined Intracervical Radiotracers and Blue Dye Injections for Endometrial Cancer
1Preventative Gynecology Research Center, Shahid Beheshti university of Medical Sciences, Tehran, Iran.
2Nuclear Medicine Department, Imam Hossein Hospital, Shahid Beheshti university of Medical Sciences, Tehran, Iran
3Radiology Technologist, Nuclear Medicine Department, Shahid Beheshti university of Medical Sciences, Tehran, Iran.
Abstract
Background: Lymphadenectomy, as part of the initial surgical staging of patients with endometrial carcinoma, remains a controversial topic in gynecologic oncology. Sentinel lymph node (SLN) mapping has become a well-accepted procedure for melanomas and breast cancer; a number of investigators have begun to explore the utility and accuracy of this technique with regard to endometrial cancer. Aim: This study was conducted to evaluate SLN mapping of early stage endometrial cancer with blue dye in conjunction with a radioactive tracer. Subjects and methods: In this prospective cross-sectional study, patients with stage I and II endometrial cancer who were candidates for systemic lymph node dissection during surgery were enrolled, some underwent lymph node mapping and SLN biopsy using combined intra cervical radiotracer and blue dye injections and some applying only an intra cervical radiotracer. SLNs and other lymph nodes were sent for pathological assessment. Sensitivity, specificity, the positive predictive value, and the negative predictive value were calculated as predictive values for the radiotracer and blue dye. Results: Pre-operative lymph node mapping showed SLN in 29 out of 30 patients. Intra operations in 29/30 patients, SLNs were harvested by gamma probe; in 13 out of 19 patients SLNs were detected by blue dye. The median number of SLNs per patient was 3 and the total number of SLNs detected was 81. Four patients had positive pelvic lymph nodes. All of the positive nodes were SLNs. Using this technique (radiotracer and blue dye) an overall detection rate of 96.7%, an NPV of 100%, a sensitivity of 100% and a specificity of 3.85% were achieved. Conclusion: Results of SLN research for endometrial cancer are promising and make feasible the possibility of avoiding unnecessary aggressive surgical procedures in near future by advances in SLN mapping.
Top